CLINICAL_TRIALS
research
· 2026-03-24
Clinical Trial Update: Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365') [NA]
Summary
Clinical trial update for the Orbera365 intragastric balloon system by Boston Scientific for weight loss; the study is NOT_YET_RECRUITING.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Weight Loss | NA | Status: NOT_YET_RECRUITING